Title : A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells.

Pub. Date : 2019

PMID : 31551763






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Our data suggested that DLD-1 colon cancer cells with BAX/BAK double-knockout were selectively resistant to a panel of FDA-approved drugs (27 out of 66), including etoposide. Etoposide BCL2 associated X, apoptosis regulator Homo sapiens